INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• How Cara Therapeutics Increased Compliance And Reduced Study Team Burden

  Delve into the partnership that helped Cara Therapeutics achieve a significant milestone in their clinical research efforts to transform the lives of chronic pruritus patients.

• Challenges And New Approaches To Developing Clinical Evidence For Medical Devices

  Learn about the challenges and new approaches to developing clinical evidence for medical devices, including decentralized trials, adaptive studies, in silico trials, and real-world evidence.

• Vaccine Solutions Demo

  Vaccine Solutions is an integrated software bundle streamlining Phase 2 and 3 vaccine trials by centralizing consent forms, records, and essential documents for easy access and efficiency.

• Monitoring Activity And Gait In Children Using DHTs

  Drug developers, researchers, patients, and regulators are recognizing the benefits of sensor-based digital health technologies for clinical research.

• The Innovations Shaping 2026 CNS Clinical Trials

  2/27/2026

  Explore how AI, digital tools, and site‑centered design can reduce burden, strengthen data quality, and support more reliable trial execution.

• The Future Of Pharmacovigilance: Integrating AI

  4/1/2025

  The use of AI in pharmacovigilance can enhance processes such as data analysis, signal detection, and case management by increasing efficiency, accuracy, and the ability to manage large datasets.

• Overcoming Participant Compliance Challenges In A Medical Device Study

  9/9/2024

  Uncover how Catalyst Clinical Research enhanced participant compliance and streamlined scheduling for a TENS device study using the TrialKit platform, with crucial support from CDS.

• Outlook 2025: Key Trends & Insights

  2/19/2025

  Dive into the key trends and challenges shaping the year ahead, from geopolitical uncertainties to cutting-edge innovation in AI, oncology, and weight-loss therapies.

• The Hidden Complexity Of Ophthalmic Protocol Requirements

  3/21/2025

  Explore the critical role of meticulously planning ophthalmic assessments in clinical trials, highlighting their potential risks and complexities.